Moa Fransson
Directeur/Membre du Conseil chez ENZYMATICA AB
Profil
Moa Fransson is the founder of Bioflow Systems AB.
She is currently the Chief Executive Officer of Genagon Therapeutics AB and Director at Enzymatica AB.
She holds a doctorate degree from the University of Uppsala.
Postes actifs de Moa Fransson
| Sociétés | Poste | Début |
|---|---|---|
| ENZYMATICA AB | Directeur/Membre du Conseil | 01/05/2022 |
Genagon Therapeutics AB
 Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Directeur Général | 01/12/2019 |
Anciens postes connus de Moa Fransson
| Sociétés | Poste | Fin |
|---|---|---|
| Bioflow Systems AB | Fondateur | - |
Formation de Moa Fransson
| University of Uppsala | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENZYMATICA AB | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genagon Therapeutics AB
Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Health Technology |
| Bioflow Systems AB |
